Revenue Revenue Recognition and Deferred Revenue (Tables)

9 Months Ended

Sep. 30, 2024

Revenue Recognition and Deferred Revenue [Abstract]

Revenue from External Customers by Geographic Areas

The following tables present our revenue disaggregated by geographic area, species and major product category:

Revenue by geographic area

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(MILLIONS OF DOLLARS)	2024		2023		2024		2023
United States	$	1,346	$	1,174	$	3,817	$	3,344
Australia	83		84		239		248
Brazil	101		101		301		276
Canada	66		63		202		183
Chile	31		31		93		109
China	61		69		205		255
France	36		34		111		102
Germany	57		50		166		148
Italy	31		26		95		87
Japan	33		34		109		120
Mexico	39		42		129		119
Spain	35		30		100		94
United Kingdom	80		78		230		209
Other developed markets	148		127		413		374
Other emerging markets	220		187		670		605
	2,367		2,130		6,880		6,273
Contract manufacturing & human health	21		21		59		58
Total Revenue	$	2,388	$	2,151	$	6,939	$	6,331

Revenue from External Customers by Major Species

Revenue by major species

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(MILLIONS OF DOLLARS)	2024		2023		2024		2023
U.S.
Companion animal	$	1,068	$	908	$	3,046	$	2,588
Livestock	278		266		771		756
	1,346		1,174		3,817		3,344
International
Companion animal	541		506		1,662		1,540
Livestock	480		450		1,401		1,389
	1,021		956		3,063		2,929
Total
Companion animal	1,609		1,414		4,708		4,128
Livestock	758		716		2,172		2,145
Contract manufacturing & human health	21		21		59		58
Total Revenue	$	2,388	$	2,151	$	6,939	$	6,331

Revenue from External Customers by Species

Revenue by species

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(MILLIONS OF DOLLARS)	2024		2023		2024		2023
Companion Animal:
Dogs and Cats	$	1,551	$	1,354	$	4,516	$	3,931
Horses	58		60		192		197
	1,609		1,414		4,708		4,128
Livestock:
Cattle	391		374		1,132		1,102
Poultry	139		127		410		397
Swine	131		129		388		404
Fish	70		57		177		158
Sheep and other	27		29		65		84
	758		716		2,172		2,145
Contract manufacturing & human health	21		21		59		58
Total Revenue	$	2,388	$	2,151	$	6,939	$	6,331

Schedule of Significant Product Revenues

Revenue by major product category

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
(MILLIONS OF DOLLARS)	2024		2023		2024		2023
Parasiticides	$	530	$	465	$	1,634	$	1,465
Vaccines	468		449		1,365		1,308
Dermatology	453		397		1,234		1,048
Anti-infectives	274		264		819		796
Pain and sedation	219		147		634		408
Other pharmaceutical	169		166		478		514
Animal health diagnostics	101		95		286		284
Medicated feed additives	91		86		242		257
Other non-pharmaceutical	62		61		188		193
	2,367		2,130		6,880		6,273
Contract manufacturing & human health	21		21		59		58
Total Revenue	$	2,388	$	2,151	$	6,939	$	6,331